8.00 – 8.30
On site registration and welcome
8.30 – 9.00
Vasculogenesis and angiogenesis
T. Naidich, USA
9.00 – 9.30
Normal cerebral vessels walls : histology, biology, perivascular spaces
M. Catala, France
9.30 – 10.00
Normal cerebral vascular wall ageing-arteries and veins
W.E Sonntag, USA
10.00 – 10.30
Intracranial vasa vasorum. Implication in neurovascular diseases Including atherosclerosis
B. Wasserman, USA
10.30 – 11.00
Coffee break
11.00 – 11.30
Vessel Wall inflammation and consequences
P. Berlit, Germany
11.30 – 12.00
Vessel wall imaging: from normal to pathological
B. T. Naidich, USA
12.00 – 12.30
Intracranial dissections and therapeutic considerations
G. Rodesch, France
12.30 – 13.30
Lunch break
13.30 – 14.00
Genetic aspects of congenital vasculopathies including HHT
M. Vikkula, Belgium
14.00 – 14.30
Phenotypic aspects of inherited vasculopathies : vascular Ehlers Danlos syndrome
X. Jeunemaître, France
14.30 – 15.00
Phenotypic aspects of congenital vasculopathies : HHT
S. Dupuis Girod, France
15.00 – 15.30
15.30 – 16.00
Specificities of endovascular treatments in congenital vasculopathies
A. Berenstein, USA
16.00- 16.30
Intracranial arteries stenosis : treatments
M. Marks, USA
16.30 – 17.00
Endovascular treatments: consequences on vessel walls
H. Benamer, France
17.00 – 17.30
Embolic materials and vascular wall
P. Gobin, USA
Bienvenue
Metameric origin of cerebral arteries
M. Tanaka, Japan
Shear stress and vascular wall
G. Finet, France
Aneurysmal vasculopathy : from unrupture to rupture
J. Frosen, Finland
Aneurysmal wall imaging
R. VandenBerg, Netherlands
Discussion and round table : impact in pre therapeutic aneurysm assessment
M. Soderman, Sweden
11.30 – 12.30
Role of vessel wall in unruptured to ruptured cerebral AVMs
S. Hetts, USA
12.30 – 13.00
Angiogenesis and brain AVMs
Angiogenesis in pediatric population and recurrence of AVMs
D. Orbach, USA
13.00 – 13.30
Cerebral proliferative angiopathies
A. Valavanis, Switzerland
13.30 – 14.30
Discussion and round table: impact in pre therapeutic cerebral AVMs assessment
S. Bracard, France
CAMS and angiogenesis in the maxillofacial area
L. Boon, Belgium
Angiogenesis in Moya moya and progressive arterial stenosis
M. Komiyama, Japan
16.00 – 16.30
Anti angiogenic treatments
Cerebral collateral circulation
17.00
Conclusions and End of the Seminar